Vertex Pharmaceuticals Inc (VRTX)
418.99
+0.17
(+0.04%)
USD |
NASDAQ |
May 09, 16:00
419.22
+0.23
(+0.05%)
After-Hours: 20:00
Vertex Pharmaceuticals Profit Margin (Quarterly): 40.87% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 40.87% |
December 31, 2023 | 38.48% |
September 30, 2023 | 41.69% |
June 30, 2023 | 36.73% |
March 31, 2023 | 29.47% |
December 31, 2022 | 35.56% |
September 30, 2022 | 39.86% |
June 30, 2022 | 36.90% |
March 31, 2022 | 36.33% |
December 31, 2021 | 37.16% |
September 30, 2021 | 42.94% |
June 30, 2021 | 3.74% |
March 31, 2021 | 37.88% |
December 31, 2020 | 37.12% |
September 30, 2020 | 43.39% |
June 30, 2020 | 54.92% |
March 31, 2020 | 39.78% |
December 31, 2019 | 41.27% |
September 30, 2019 | 6.06% |
June 30, 2019 | 28.41% |
March 31, 2019 | 31.29% |
December 31, 2018 | |
September 30, 2018 | 16.41% |
June 30, 2018 | 27.57% |
March 31, 2018 | 32.81% |
Date | Value |
---|---|
December 31, 2017 | 15.45% |
September 30, 2017 | -17.81% |
June 30, 2017 | 3.31% |
March 31, 2017 | 34.66% |
December 31, 2016 | 7.18% |
September 30, 2016 | -9.39% |
June 30, 2016 | -14.95% |
March 31, 2016 | -10.46% |
December 31, 2015 | -17.64% |
September 30, 2015 | -30.71% |
June 30, 2015 | -113.7% |
March 31, 2015 | -143.4% |
December 31, 2014 | -122.2% |
September 30, 2014 | -95.01% |
June 30, 2014 | -115.1% |
March 31, 2014 | -196.2% |
December 31, 2013 | 12.61% |
September 30, 2013 | -55.99% |
June 30, 2013 | -18.40% |
March 31, 2013 | -93.80% |
December 31, 2012 | -22.80% |
September 30, 2012 | -17.13% |
June 30, 2012 | -15.52% |
March 31, 2012 | 20.88% |
December 31, 2011 | 28.16% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
3.74%
Minimum
Jun 2021
54.92%
Maximum
Jun 2020
35.43%
Average
37.52%
Median
Profit Margin (Quarterly) Benchmarks
Amgen Inc | -1.52% |
Eli Lilly and Co | 25.58% |
Regeneron Pharmaceuticals Inc | 22.96% |
Alpine Immune Sciences Inc | 19.32% |
Editas Medicine Inc | -5.46K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 24.35% |
Return on Assets | 18.66% |
Return on Invested Capital | 24.35% |
Gross Profit Margin (Quarterly) | 87.27% |
Operating Margin (Quarterly) | 45.20% |
Return on Net Operating Assets | 71.50% |